629 related articles for article (PubMed ID: 29326545)
1. Apolipoprotein Eε4: A Biomarker for Executive Dysfunction among Parkinson's Disease Patients with Mild Cognitive Impairment.
Samat NA; Abdul Murad NA; Mohamad K; Abdul Razak MR; Mohamed Ibrahim N
Front Neurosci; 2017; 11():712. PubMed ID: 29326545
[No Abstract] [Full Text] [Related]
2. Global assessment, cognitive profile, and characteristics of mild cognitive impairment in Parkinson's disease.
Yang J; Pourzinal D; Byrne GJ; McMahon KL; Copland DA; O'Sullivan JD; Mitchell L; Dissanayaka NN
Int J Geriatr Psychiatry; 2023 Jun; 38(6):e5955. PubMed ID: 37318156
[TBL] [Abstract][Full Text] [Related]
3. Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson's disease.
Badrkhahan SZ; Sikaroodi H; Sharifi F; Kouti L; Noroozian M
Appl Neuropsychol Adult; 2020; 27(5):431-439. PubMed ID: 30821505
[TBL] [Abstract][Full Text] [Related]
4. A New Instrument Combines Cognitive and Social Functioning Items for Detecting Mild Cognitive Impairment and Dementia in Parkinson's Disease.
Yu YW; Tan CH; Su HC; Chien CY; Sung PS; Lin TY; Lee TL; Yu RL
Front Aging Neurosci; 2022; 14():913958. PubMed ID: 35783135
[TBL] [Abstract][Full Text] [Related]
5. Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
Liang K; Li X; Guo Q; Ma J; Yang H; Fan Y; Yang D; Shi X; She Z; Qi X; Gu Q; Chen S; Zheng J; Li D
Neurobiol Dis; 2024 Jan; 190():106379. PubMed ID: 38104911
[TBL] [Abstract][Full Text] [Related]
6. Application of the Chinese Version of the Montreal Cognitive Assessment-Basic for Assessing Mild Cognitive Impairment in Parkinson's Disease.
Xu Q; Zhou M; Jiang C; Wu L; He Q; Zhao L; Dong Y; Liu J; Chen W
Brain Sci; 2021 Nov; 11(12):. PubMed ID: 34942877
[TBL] [Abstract][Full Text] [Related]
7. Impact of Cognitive Profile on Impulse Control Disorders Presence and Severity in Parkinson's Disease.
Martini A; Weis L; Fiorenzato E; Schifano R; Cianci V; Antonini A; Biundo R
Front Neurol; 2019; 10():266. PubMed ID: 30967834
[No Abstract] [Full Text] [Related]
8. Domain specific cognitive impairment in Parkinson's patients with mild cognitive impairment.
Chaudhary S; Kumaran SS; Kaloiya GS; Goyal V; Sagar R; Kalaivani M; Jaganathan NR; Mehta N; Srivastava A
J Clin Neurosci; 2020 May; 75():99-105. PubMed ID: 32192853
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Italian version of the Parkinson's Disease- Cognitive Functional Rating Scale.
Garon M; Weis L; Siquier A; Fiorenzato E; Pistonesi F; Cianci V; Canesi M; Pesce F; Reali E; Pozzi B; Isaias IU; Siri C; Santangelo G; Cuoco S; Barone P; Kulisevsky J; Antonini A; Biundo R
J Neural Transm (Vienna); 2024 Apr; 131(4):305-314. PubMed ID: 38280057
[TBL] [Abstract][Full Text] [Related]
10. White matter damage in patients with mild cognitive impairment in Parkinson's disease.
Li QQ; Wu K; Xu JL; Yin L
Quant Imaging Med Surg; 2022 Feb; 12(2):1290-1298. PubMed ID: 35111624
[TBL] [Abstract][Full Text] [Related]
11. A task-specific cognitive domain decline is correlated with plasma and neuroimaging markers in patients with Parkinson's disease.
Li CH; Chen TF; Peng PL; Lin CH
J Neurol; 2022 Dec; 269(12):6530-6543. PubMed ID: 35965282
[TBL] [Abstract][Full Text] [Related]
12. Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression.
Wallace ER; Segerstrom SC; van Horne CG; Schmitt FA; Koehl LM
Neuropsychol Rev; 2022 Mar; 32(1):149-160. PubMed ID: 33860906
[TBL] [Abstract][Full Text] [Related]
13. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
[TBL] [Abstract][Full Text] [Related]
14. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
Hobson P; Meara J
Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
[TBL] [Abstract][Full Text] [Related]
15. Plasma α-synuclein predicts cognitive decline in Parkinson's disease.
Lin CH; Yang SY; Horng HE; Yang CC; Chieh JJ; Chen HH; Liu BH; Chiu MJ
J Neurol Neurosurg Psychiatry; 2017 Oct; 88(10):818-824. PubMed ID: 28550072
[TBL] [Abstract][Full Text] [Related]
16. Is the Random Forest Algorithm Suitable for Predicting Parkinson's Disease with Mild Cognitive Impairment out of Parkinson's Disease with Normal Cognition?
Byeon H
Int J Environ Res Public Health; 2020 Apr; 17(7):. PubMed ID: 32290134
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Mild Cognitive Impairment and Dementia in Parkinson's Disease: The Parkinson's Disease Cognitive Impairment Study.
Nicoletti A; Luca A; Baschi R; Cicero CE; Mostile G; Davì M; Pilati L; Restivo V; Zappia M; Monastero R
Front Aging Neurosci; 2019; 11():21. PubMed ID: 30800065
[No Abstract] [Full Text] [Related]
18. Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson's disease patients.
Sulzer P; Becker S; Maetzler W; Kalbe E; van Nueten L; Timmers M; Machetanz G; Streffer J; Salvadore G; Scholz E; Tkaczynska Z; Brockmann K; Berg D; Liepelt-Scarfone I
J Neurol; 2018 Sep; 265(9):1976-1984. PubMed ID: 29936665
[TBL] [Abstract][Full Text] [Related]
19. Abnormal MoCA and normal range MMSE scores in Parkinson disease without dementia: cognitive and neurochemical correlates.
Chou KL; Lenhart A; Koeppe RA; Bohnen NI
Parkinsonism Relat Disord; 2014 Oct; 20(10):1076-80. PubMed ID: 25085750
[TBL] [Abstract][Full Text] [Related]
20. Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease.
Kandiah N; Zhang A; Cenina AR; Au WL; Nadkarni N; Tan LC
Parkinsonism Relat Disord; 2014 Nov; 20(11):1145-8. PubMed ID: 25176439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
